ArticleThe American journal of pathology2009

Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis.

Angélica T Vieira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.